Kerala Ayurveda logo

Kerala Ayurveda financials and balance sheet

BSE: 530163Pharmaceuticals & BiotechnologySmall Cap

Last close ₹131.25down ₹8.50 (6.08%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹139.75.

52-week range of traded prices to 23 Oct 2026
₹130.00Low, 23 Oct 2026₹448.00High, 29 Oct 2025
Market cap
₹171 Cr2,181st largest listed
P/E
Lossover the last 12 months
P/B
15.3
Dividend yield
Nonein the last 12 months
ROE
−257.3%
ROCE
−24.1%
Debt to equity
5.43
Volume, BSE
9,945

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Kerala Ayurveda annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 5 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out.

The years either side of a change of basis do not compare. From the year to Mar 2023, the company's revenue for that year, ₹89 Cr, differs from its quarters added, ₹92 Cr. From the year to Mar 2024, the company's revenue for that year, ₹102 Cr, differs from its quarters added, ₹104 Cr. From the year to Mar 2025, the company's revenue for that year, ₹120 Cr, differs from its quarters added, ₹123 Cr.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue131
  2. Materials and goods−28
  3. Employee costs−67
  4. Other expenses−54
  5. Operating profit−18
  6. Depreciation−5.5
  7. Other income+14
  8. One-off items0.0
  9. Finance costs−7.3
  10. Profit before tax−16
  11. Tax0.0
  12. Net profit−16

What the company owns

  • Plant, investments and other assets₹104 Cr
  • Inventory₹15 Cr
  • Receivables₹14 Cr
  • Cash and bank₹6 Cr

What pays for it: net worth and liabilities

  • Borrowings₹81 Cr
  • Other liabilities₹33 Cr
  • Net worth₹15 Cr
  • Owed to suppliers₹10 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Kerala Ayurveda quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 8 JunMar 2020Filed 6 JulMar 2021Filed 15 JulMar 2022Filed 14 JunMar 2023Filed 1 JunMar 2024Filed 2 AugMar 2025Filed 8 AugMar 2026Filed 13 Jul
Revenue from operations50565973597689102120131
4348546658678796125149
Materials and goods bought11111415151720222328
Employee costs16182125222228345467
Other expenses16191926212739404854
Operating profit before depreciation78571926−5−18
Operating margin14.0%13.6%8.4%9.7%1.3%12.3%2.5%6.0%−4.1%−13.5%
Materials, % of revenue22.0%20.2%23.1%20.5%25.4%22.5%22.5%21.5%18.9%21.0%
Employee costs, % of revenue32.0%31.9%35.5%33.7%37.3%29.2%31.5%33.5%45.1%51.1%
Other expenses, % of revenue32.1%34.3%33.0%36.1%36.0%35.9%43.5%39.1%40.2%41.4%
Depreciation and amortisation2211111155
Operating profit after depreciation5646−1815−10−23
Other income00000001214
Finance costs1222675447
Profit before one-off items and tax–425−72−31−12−16
One-off items0010013000
Profit before tax4435−73−11−12−16
1110−200220
Share of profit of joint ventures and associates––––––––−1–
3334−520−1−15−16
Other comprehensive income––−1−10000−1−4
Total comprehensive income––13−530−1−15−20
Net margin6.2%5.0%4.3%5.6%−8.2%3.1%−0.5%−0.8%−12.2%−12.4%
Net margin without joint ventures and associates––––––––−11.6%–
Belonging to the company's shareholders is left blank for the year to Mar 2018: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the share it leaves the other owners is more than 10 points from the share the company's other periods state. Belonging to the company's shareholders is left blank for the years to Mar 2021 and Mar 2023: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the period is a loss, which leaves no share to compare with the company's other periods.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 8 JunMar 2020Filed 6 JulMar 2021Filed 15 JulMar 2022Filed 14 JunMar 2023Filed 1 JunMar 2024Filed 2 AugMar 2025Filed 8 AugMar 2026Filed 13 Jul
510588351315
4836632911
Share capital1111111111121213
Reserves−7−3−7−4−520−3−2
Belonging to outside owners of subsidiaries22222334
6664777074686681
3231346053408899
5563754255652824
92103114110116141129138
6470717381818892
2833443735604145
Net debt6158586769456375
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 15 JulMar 2022Filed 14 JunMar 2023Filed 1 JunMar 2024Filed 2 AugMar 2025Filed 8 AugMar 2026Filed 13 Jul
7.4−0.510.22.04.8−24.1
7.4−0.210.3−1.06.9−24.1
6.3−11.14.6−3.64.6−13.1
Receivables0.4−3.00.4−2.8−2.16.9
Inventories1.8−1.0−0.5−3.0−0.7−6.9
Payables−0.51.8−0.10.3−1.14.0
Other working capital4.6−8.94.92.08.4−17.2
Tax paid0.00.00.0−1.3−2.0−0.1
Interest paid0.00.00.04.50.00.0
Capital spending1.02.86.21.113.35.6
Free cash flow6.4−3.44.00.9−8.5−29.7
−1.4−1.9−7.2−1.3−14.8−5.5
6.2−13.3−1.517.6−9.532.4
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.028.20.00.0
Net change in cash12.2−15.81.518.4−19.42.8
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 8 JunMar 2020Filed 6 JulMar 2021Filed 15 JulMar 2022Filed 14 JunMar 2023Filed 1 JunMar 2024Filed 2 AugMar 2025Filed 8 AugMar 2026Filed 13 Jul
Earnings per share₹2.96₹0.89––−₹3.50–−₹3.19−₹1.30−₹12.79−₹30.53
Diluted earnings per share₹2.96₹0.89––−₹3.50–−₹0.51−₹1.30−₹12.79−₹30.53
Book value per share––₹3.53₹7.51₹3.22₹5.79₹5.28₹26.73₹7.89₹8.56
Shareholder yield––––0.0%0.0%0.0%−9.0%0.0%0.0%
Market cap at the year end (₹ crore)98897139548288314423205
Earnings per share is left blank for the year to Mar 2019: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown. Earnings per share is left blank for the years to Mar 2020 and Mar 2022: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Consolidated, years to March.Kerala Ayurveda PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 8 JunMar 2020Filed 6 JulMar 2021Filed 15 JulMar 2022Filed 14 JunMar 2023Filed 1 JunMar 2024Filed 2 AugMar 2025Filed 8 AugMar 2026Filed 13 Jul
Revenue growth–10.7%5.6%24.0%−19.3%29.3%–––9.0%
Operating profit growth–8.1%−35.1%43.4%−89.4%1,152.3%––––
Net profit growth–−10.3%−10.1%60.6%––––––
Earnings per share growth–−69.9%––––––––
––65.6%66.9%–49.7%–−8.1%−74.1%−160.6%
–––1.3 pts––––−66.0 pts−86.5 pts
From the net margin–––18.8 pts––––−61.5 pts1.2 pts
From asset turnover–––14.5 pts––––−8.3 pts−7.3 pts
From borrowing–––−32.0 pts––––3.8 pts−80.4 pts
Return on capital employed––5.5%8.0%−0.6%10.5%1.4%4.7%−12.6%−24.3%
Cash conversion–––––−21.0%––––
Interest cover4.33.11.63.8–1.30.21.1––
Debt to equity––12.296.6014.748.809.341.925.125.43
Receivable days––4354646453565938
Inventory days––311313268255227258208200
Payable days––11716214916813712993129
Cash conversion cycle, days––236204183150144185174109
Working capital days––5039832618−816
Asset turnover––0.640.750.540.680.790.800.890.98
Assets per rupee of net worth––24.7716.7619.2023.6219.356.806.4712.96
Sales per rupee of plant––2.653.252.703.483.724.283.883.98
Capital spending to depreciation––––0.822.375.580.832.681.02
Plant being built, % of plant in use––54.2%60.9%64.5%20.3%28.5%28.6%29.7%23.2%
Interest cover is left blank for the years to Mar 2021, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth and operating profit growth are left blank for the years to Mar 2023 and Mar 2024: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Revenue growth is left blank for the year to Mar 2025: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
−12.4%
Measure10 years5 years3 years
Revenue growth, yearly rate–17.3%13.7%
Return on equity, average–−48.3%−80.9%
Return on capital employed, average–−4.1%−10.7%
Operating margin, average5.0%0.6%−3.9%
Net margin, average−1.0%−4.6%−8.5%
Asset turnover, average–0.830.89
Cash conversion cycle, days, average–152156
Debt to equity, average–6.124.16

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−7.5−17.3−24.1
Cash from investing−30.6−21.5−5.5
Cash from financing25.740.532.4
Capital spending29.120.15.6
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash28.228.20.0
Borrowings raised–47.538.5
Borrowings repaid34.224.71.4

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––466642
Altman Z-scorePublished threshold 1.81––1.171.140.811.151.143.012.451.24
Beneish M-scorePublished threshold −1.78––––−3.01−2.13−2.87−2.38−3.23−2.49
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−9.964.28−3.04−1.28−3.539.95
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––––10.67––
Receivables growth less revenue growthOur threshold 0 percentage points–––31.3115.71−0.20−19.837.224.59−37.43
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––0.72−14.43−5.73−12.4514.56−19.75−4.98
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−3.011.196.82−3.970.56−0.813.90
Assets under construction, years of additionsOur threshold 2 years of additions–––10.1320.943.482.165.470.761.04
Effective tax ratePublished threshold 17.16 per cent21.1830.8918.5510.67–14.66–167.89––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––14.66–69.00––
A threshold marked as ours has no published figure; it is the line we read the check against.